Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus

NCT06498960 is registered in ClinicalTrials.gov with CereVasc Inc as lead sponsor.

NCT NCT06498960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06498960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus
Lead sponsor
CereVasc Inc
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 26, 2024
Completion date
July 31, 2031
Enrollment
230 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

normal pressure hydrocephalus